BioNexus Gene Lab issues 410,000 shares for $3.5M licence
BioNexus Gene Lab (BGLC) is issuing 410,000 common shares at closing as licence consideration of $3.5 million.
Story updates
12:50:34 PM UTC
SquawkNews
* BioNexus Gene Lab to Issue Another 150,000 Common Shrs in Exchange for 500,000 RYET Ordinary Shrs, for 560,000 Shrs in Total >BGLC